Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
influenza vaccine GSK2604409A
- Development stage
- Approved
- Lead developer
- GSK
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Influenza vaccine GSK2604409A is an investigational quadrivalent inactivated split virion influenza vaccine developed by GSK (GlaxoSmithKline). It is designed to provide immunization against four strains of influenza virus, specifically including A/California/7/2009 (H1N1)-like, A/Perth/16/2009 (H3N2)-like, B/Brisbane/60/08 (Victoria lineage), and B/Brisbane/3/07 (Yamagata lineage). The vaccine is administered as a suspension for injection via the intramuscular route. Clinical trials have evaluated its safety and immunogenicity in children aged 6 months to 17 years, with dosing regimens adjusted based on age and prior priming status. The primary indication is prevention of influenza[2][7].
- Other names
- Influenza vaccine GSK2604409A
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on influenza vaccine GSK2604409A.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on influenza vaccine GSK2604409A.